Molecular Genetics & Genomic Medicine (Oct 2019)

Retracted: MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1

  • Guo‐shu Xu,
  • Zi‐wei Li,
  • Zhi‐Ping Huang,
  • F. Charles Brunicardi,
  • Fu Jia,
  • Chao Song,
  • Hai‐jian Zou,
  • Rui‐fen Sun

DOI
https://doi.org/10.1002/mgg3.860
Journal volume & issue
Vol. 7, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Background MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR‐497‐5p has been reported in various human malignancies. However, the role of miR‐497‐5p in hepatocellular carcinoma (HCC) remains unclear. Results In this study, we found that miR‐497‐5p was downregulated in HCC tissues. The low level of miR‐497‐5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor prognosis in HCC patients. The overexpression of miR‐497‐5p significantly inhibited HCC cell proliferation, colony formation, and metastasis in vitro and vivo. Bioinformatics analysis further identified insulin‐like growth factor 1 (IGF1) as a novel target of miR‐497‐5p in HCC cells. Conclusion Our study suggested that miR‐497‐5p regulates HCC cell survival, partially through downregulation of IGF1. Therefore, the miR‐497‐5p/IGF1 axis might serve as a novel therapeutic target in patients with HCC.

Keywords